Agfa-Gevaert (ENXTBR:AGFB) Valuation in Focus After Q3 Earnings Reveal Wider Quarterly Losses and Sales Dip

Agfa-Gevaert (ENXTBR:AGFB) just released its third quarter and nine-month 2025 earnings results. The report shows that sales have dipped and net losses have widened this quarter compared to the same period last year.

See our latest analysis for Agfa-Gevaert.

Agfa-Gevaert’s latest trading has been turbulent, with the share price dropping sharply by 20% over the past week and now sitting at $0.625. Looking at the bigger picture, momentum is clearly weak, as the 1-year total shareholder return stands at -6.7%. Longer-term investors have faced more severe declines, which highlights persistent challenges even before this quarter’s sales dip and widening loss came into focus.

If the recent earnings update has you rethinking your next move, now’s the perfect time to broaden your exploration and discover fast growing stocks with high insider ownership

With such a sharp drop in share price and lingering questions about Agfa-Gevaert’s turnaround prospects, is the current valuation a potential entry point for value seekers, or is the market already factoring in future challenges?

Most Popular Narrative: 88% Undervalued

According to RecMag, the latest narrative suggests Agfa-Gevaert’s fair value is dramatically higher than the recent closing price of $0.625. The narrative frames today’s price as deeply discounted and highlights decisive shifts within the business that could be catalytic.

“The divestment of the Offset Solutions division in 2023 was Agfa's most significant restructuring in over a decade. This business unit, which in the 2022 financial year was still responsible for nearly a fifth of total revenue (€779 million), was transferred to Aurelius Group and renamed ECO3. Thanks to the deal, Agfa continues to supply consumables and technical services to the former division, ensuring recurring income without the heavy capital requirements of the offset printing industry. This simplified the company's structure and enabled management to concentrate on higher-margin and more defensible segments.”

Read the complete narrative.

Why are some investors eyeing a massive upside despite years of decline? The calculation behind this bold fair value hints at rapid profit growth, major structural cost cuts, and a striking shift from legacy print to digital health and advanced materials. Want to see what powerful growth levers could support such a sharp re-rating?

Result: Fair Value of $5.39 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing pension liabilities and persistent declines in medical film revenue could undermine even a well-executed turnaround. These factors may also delay any long-term recovery.

Find out about the key risks to this Agfa-Gevaert narrative.

Build Your Own Agfa-Gevaert Narrative

If you see the numbers differently or find new angles worth investigating, why not dive in and craft your own narrative in just a few minutes? Do it your way

A great starting point for your Agfa-Gevaert research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

Spotting smart opportunities goes beyond just one company. Put your strategy into action and find your next potential winner with these powerful hand-picked screens.

• Supercharge your portfolio with high-yield plays by targeting these 17 dividend stocks with yields > 3%, which offers steady income potential and attractive returns even in a volatile market.
• Jump ahead of tech trends by checking out these 25 AI penny stocks, which are pushing boundaries in artificial intelligence innovation and reshaping entire industries.
• Capitalize on hidden gems by searching for these 918 undervalued stocks based on cash flows, which the market may be overlooking and could give you a shot at early-mover advantage.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com